SASE:4164

2 stories mentioning SASE:4164Updated 27d ago

Every FINWIRES story that references SASE:4164, newest first.

Morgan Stanley Lowers Nahdi Medical's PT, Keeps at Overweight

Morgan Stanley on Thursday reduced the price target for Saudi Arabian retail pharmacy and healthcare company Nahdi Medical (SASE:4164) to 120 Saudi riyals from 135 riyals and affirmed its overweight rating.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

SASE:4164

Research48d ago

Riyad Capital Downgrades Nahdi Medical to Neutral, Trims PT

Riyad Capital on Thursday downgraded pharmaceutical retailer Nahdi Medical (SASE:4164) to neutral from buy and decreased its price target to 105 Saudi riyals from 115 riyals.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

SASE:4164

Track with the FINWIRES app suite

FolioX

Track SASE:4164 in your portfolio

WheelAI

Analyze SASE:4164 options with the wheel strategy

StockInsider

See market sentiment on SASE:4164